Table 1 Baseline characteristics of study sample. Mean (SD)
From: Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis
| Â | 0.03 mg (N = 7) | 0.1 mg (N = 6) | 0.3 mg (N = 6) | 1 mg (N = 6) | All (N = 25) | Placebo (N = 8) | All Participants (N = 33) |
|---|---|---|---|---|---|---|---|
Age in years | 60.1 (11.2) | 58.5 (5.3) | 62.2 (15.8) | 58.5 (5.6) | 59.8 (9.9) | 59.8 (6.5) | 59.8 (9.1) |
BMI. kg/m 2 | 35.7 (8.7) | 35.6 (10.9) | 33.0 (7.2) | 35.8 (8.2) | 35.0 (8.3) | 31.6 (5.8) | 34.2 (7.9) |
Gender (n (%) female) | 3 (43%) | 6 (100%) | 5 (83%) | 4 (67%) | 18 (72%) | 6 (75%) | 24 (73%) |